Document:

EXHIBIT 4.7

                                ALLIED DOMECQ PLC

                         RULES OF THE ALLIED DOMECQ PLC

                         LONG TERM INCENTIVE SCHEME 1999

                    Directors Adoption:              25 October 1999
                    Last amended:                   [28] October 2002
                    Shareholder Approval:            29 January 2001
                    Expiry Date:                     25 October 2009

Linklaters

One Silk Street
London EC2Y 8HQ

Telephone (44-20) 7456 2000
Facsimile (44-20) 7456 2222

Ref AC

<PAGE>

RULES OF THE ALLIED DOMECQ PLC LONG TERM INCENTIVE SCHEME 1999

1    Meanings of Words Used

     In these Rules:

     "ADS" means an American depository share representing ordinary shares of
     the Company;

     "Company" means Allied Domecq PLC;

     "Control" has the meaning given to it by Section 840 of the Taxes Act;

     "Date of Grant" means the date on which the Directors resolve to grant an
     Option;

     "Directors" means the board of directors of the Company or a duly
     authorised committee of it;

     "Eligible Employee" means any person who is a full time employee of a
     Participating Company and on the Date of Grant is not within 2 years of his
     normal retirement date;

     "Member of the Group" means:

     (i)   the Company; and

     (ii)  its Subsidiaries from time to time; and

     (iii) any other company which is associated with the Company and is
           designated by the Directors as a Member of the Group;

     "NYSE" means the New York Stock Exchange;

     "Option" means a right to acquire Shares granted under the Scheme;

     "Optionholder" means a person holding an Option or his personal
     representatives;

     "Option Period" means a period starting on the Date of Grant of an Option
     and ending at the end of the day before the 10th anniversary of the Date of
     Grant or such shorter period as may be specified on the Date of Grant;

     "Option Price" means the amount payable for each Share on the exercise of
     an Option determined by the Directors under Rule 3;

     "Participating Company" means the Company and any subsidiary, and any other
     company which is designated by the Directors as a Participating Company;

     "Performance Condition" means a condition or conditions imposed under Rule
     2.3;

     "Performance Period" means the period over which a Performance Condition is
     to be satisfied;

     "Rules" means these rules as changed from time to time;

     "Scheme" means this scheme known as "The Allied Domecq Long Term Incentive
     Scheme 1999";

     "Shares" means ordinary shares or securities representing ordinary shares
     in the capital of the Company or, as the context may require, ADSs;

                                       1
<PAGE>

     "Subsidiary" means a company which is a subsidiary of the Company within
     the meaning given to it by Section 736 of the Companies Act 1985;

     "Taxes Act" means the Income and Corporation Taxes Act 1988.

2    Grant of Options

2.1  Selection:

     The Directors may grant to any Eligible Employee an Option to acquire such
     number of Shares as they may determine.

2.2  Time when Options may be granted:

     The Directors may decide at any time and at their discretion when the
     Scheme shall be operated. However, the Directors may only grant Options
     between the adoption of the Scheme and the 10th anniversary of that date.

2.3  Conditions on exercise:

     When granting an Option, the Directors shall make its exercise conditional
     on the satisfaction of a Performance Condition. The Directors may waive or
     change the Performance Condition if events happen which cause them
     reasonably to consider that a changed Performance Condition would be a
     fairer measure of performance, and would be no more difficult to satisfy,
     or that the Performance Condition should be waived.

2.4  Option Certificates:

     Each Optionholder will receive an option certificate, executed as a deed,
     or such other document as the Directors may consider appropriate, on or as
     soon as practicable after the Date of Grant.

2.5  No Payment:

     Optionholders are not required to pay for the grant of any Option.

2.6  Disposal restrictions:

     Except for the transmission of an Option on the death of an Optionholder to
     his personal representatives, neither an Option nor any rights in respect
     of it may be transferred, assigned or otherwise disposed of by an
     Optionholder to any other person.

2.7  Administrative errors:

     If the Directors try to grant an Option which is inconsistent with Rule 4
     (individual limits) the Option will be limited and will take effect from
     the Date of Grant on a basis consistent with Rule 4.

                                       2
<PAGE>

2.8  Options over ADSs:

     The Directors may determine, in their absolute discretion, to grant
     Options in the form of an Option to acquire ADSs and references in these
     Rules to Share, Option, Option Price etc. shall be construed accordingly.
     Upon the exercise of any Option to acquire ADSs the Company will:

     2.8.1  deliver or cause to be delivered to the ADS depository the requisite
            number of Shares representing the relevant ADSs and shall instruct
            the depository to issue the corresponding American Depository
            Receipts evidencing such ADSs to the exercising Optionholder; or

     2.8.2  make other arrangements for the Optionholder to acquire ADSs.

3    Option Price

     The Directors will set the Option Price on the Date of Grant. The Option
     Price may be expressed in sterling or in US dollars.

4    Individual Limits

     The Directors shall consider any limits on the grant of Options to Eligible
     Employees having regarding to the performance of the Eligible Employee and
     prevailing market practice.

5    Adjustment of Options

     If there is a variation in the equity share capital of the Company,
     including a capitalisation or rights issue, sub-division, consolidation or
     reduction of share capital, or if there is a demerger, special dividend or
     other transaction which may affect Options (directly or indirectly) the
     Directors may adjust Options in any way they consider appropriate
     (including retrospective adjustments).

6    Exercise and Lapse - General Rules

6.1  Exercise:

     Except where exercise is allowed as described in Rule 7, an Option can only
     be exercised:

     6.1.1  on or after the third anniversary of the first day of the
            Performance Period or such other date as may be specified on the
            Date of Grant; and

     6.1.2  if and to the extent that the Performance Condition is satisfied or
            waived.

6.2  Lapse:

     An Option will lapse on the earliest of:

     6.2.1 any date specified in the Performance Condition; or

     6.2.2 the expiry of the Option Period.

                                       3
<PAGE>

7    Exercise and Lapse - Exceptions to the General Rules

7.1  Cessation of Employment or Death within one year:

     If an Optionholder dies or ceases to be a director or an employee of any
     Member of the Group before the end of the first year of the Performance
     Period, his Option will lapse unless the Directors in their absolute
     discretion determine otherwise.

7.2  Cessation of Employment or Death after one year:

     7.2.1  Subject to Rule 7.2.3, if an Optionholder dies or ceases to be a
            director or an employee of any Member of the Group after the end of
            the first year of the Performance Period, his Option will be
            exercisable for a period of two years from death or cessation
            subject to satisfaction of the Performance Condition, to the extent
            specified in Rule 7.2.2. The Option will lapse, to the extent
            unexercised, at the end of the two year period.

     7.2.2  The extent to which an Option is exercisable under Rule 7.2.1 shall
            be determined by applying the following formula:

                  A x B
                  ------
                    C

                  where:

                  A = the number of Shares over which the Option is exercisable
                  under the terms of the Performance Condition;

                  B = the number of complete months from the beginning of the
                  Performance Period to the date of cessation of employment or
                  death; and

                  C = the duration of the Performance Period expressed in
                  months.

     7.2.3  The Directors may decide in their absolute discretion that an Option
            shall not be exercisable, or that an Option may be exercisable to a
            greater or lesser extent or during a longer or shorter period, or
            that the Performance Condition shall be waived or modified.

7.3  Takeovers:

     If a person (or a group of persons acting in concert) obtains Control of
     the Company, Options may be exercised, to the extent that the Performance
     Condition has been satisfied, within the six month period after the person
     making the offer has obtained Control of the Company.

     If someone becomes bound or entitled to acquire Shares under Sections 428
     to 430F of the Companies Act 1985, Options may be exercised, to the extent
     that the Performance Condition has been satisfied, at any time during the
     period when that person remains so bound or entitled. Options will lapse to
     the extent not exercised at the end of that period.

7.4  Company Reconstructions:

     If under Section 425 of the Companies Act 1985 a court sanctions a
     compromise or arrangement proposed for the purposes of or in connection
     with a scheme for the reconstruction of the Company or its amalgamation
     with any other company or companies, any Option may be exercised within six
     months of the Court sanctioning the compromise or arrangement to the extent
     that the Performance Condition has been satisfied.

                                       4
<PAGE>

7.5  Winding-Up:

     7.5.1  If notice is duly given to Members of a resolution for the voluntary
            winding-up of the Company, Options may be exercised to the extent
            that the Performance Condition has been satisfied, subject to the
            passing of the resolution, at any time until the start of the
            winding-up within the meaning of the Insolvency Act 1986. All
            Options will lapse unless exercised before the winding-up starts.

     7.5.2  If the Company is wound-up by the court, Options may be exercised,
            irrespective of the satisfaction of any Performance Condition,
            within two months after the date of the winding-up order. Any
            Options not exercised during the two month period will lapse at the
            end of the period.

7.6  Administration:

     If an administration order is made in relation to the Company, Options may
     be exercised, to the extent that the Performance Condition is satisfied,
     within six weeks after the date of the administration order.

7.7  Voluntary Arrangement:

     If a voluntary arrangement is proposed in relation to the Company under
     Part I of the Insolvency Act 1986, Optionholders may exercise their
     Options, irrespective of the satisfaction of any Performance Condition,
     within 14 days after the date of sending of any notices of meeting called
     under Section 3 of the Insolvency Act 1986 in relation to such proposal.

7.8  Loss of ownership:

     Where the Optionholder is deprived of the legal or beneficial ownership of
     the Option by operation of law, or does anything or omits to do anything
     which causes him to be so deprived or becomes bankrupt, all his Options
     will lapse.

7.9  Priority:

     If there is any conflict between any of the provisions of Rules 6 and 7,
     the provision which results in the shortest exercise period or the earliest
     lapse of the Option, or both, will prevail.

8    Exchange Of Options

8.1  Application:

     This Rule applies if a company (the "Acquiring Company"):

     8.1.1 obtains Control of the Company as a result of acquiring Shares;

                                       5
<PAGE>

     8.1.2  obtains Control of the Company under a compromise or arrangement
            sanctioned by the court under Section 425 of the Companies Act 1985;
            or

     8.1.3  becomes bound or entitled to acquire Shares under Sections 428 to
            430F of the Companies Act 1985.

8.2  Exchange:

     If any of the events described in Rule 8.1 happens, the Acquiring Company
     may, during the relevant period referred to in Rule 8.3, offer to grant an
     Optionholder an equivalent new option in consideration of the release of
     his Option.

8.3  Period for Substitution:

     The period referred to in Rule 8.2 is:

     8.3.1  in a case falling within Rule 8.1.1, 6 months starting with the time
            when the Acquiring Company obtains Control of the Company;

     8.3.2  in a case falling within Rule 8.1.2, 6 months starting with the time
            when the court sanctions the compromise or arrangement; and

     8.3.3  in a case falling within Rule 8.1.3, the period during which the
            Acquiring Company remains so bound or entitled.

     If more than one period is relevant, the period ending on the earliest date
     applies.

8.4  Consequences of Exchange:

     Where an Optionholder is granted a new option for release of his old Option
     as described in this Rule, then:

     8.4.1  the new option will be treated as having been acquired at the same
            time as the old Option and be exercisable in the same manner and at
            the same time as the old Option;

     8.4.2  the new option will be subject to the provisions of the Scheme as if
            it had effect in relation to the old Option immediately before the
            release but Rule 11.2 will not apply. In addition, other changes may
            be made;

     8.4.3  any Performance Condition will not apply, unless the directors
            determine otherwise; and

     8.4.4  these Rules will be construed in relation to the new option as if
            references to Shares were references to shares over which the new
            option is granted and as if references to the Company were
            references to the Acquiring Company.

9    Exercise of Options

9.1  Manner of Exercise:

     Options must be exercised by notice in writing delivered to the Company, in
     such form as the Company may from time to time prescribe. The Optionholder
     must also provide payment of the Option Price for the number of Shares
     being acquired.

                                       6
<PAGE>

9.2  Option Exercise Date:

     9.2.1 Subject to Rule 9.2.2 the Option Exercise Date will be the later of:-

          (i)  the date of receipt by the Company of the notice referred to in
               Rule 9.1; and

          (ii) the date on which the Directors decide that the Performance
               Condition has been satisfied, or decide to waive the Performance
               Condition.

     9.2.2  If any statute, regulation or code adopted by the Company (based on
            the London Stock Exchange's Model Code for security transactions by
            directors of listed companies), prohibits the exercise of Options,
            or the Company Secretary reasonably believes it so prohibits, the
            Option Exercise Date will be postponed until the date when the
            Optionholder is permitted or the Company Secretary believes the
            Optionholder is permitted to exercise an Option. This Rule does not
            extend any period in which an Option is exercisable.

9.3  Part Exercise:

     An Option may be exercised in full or in part. If an Option is exercised in
     part, the Optionholder shall be provided with an option certificate or
     other document in respect of the balance.

9.4  Alternative Exercise:

     The directors may in their discretion determine that an Optionholder who
     exercises his Option shall not receive Shares, and shall not pay the Option
     Price, but shall instead receive either a cash amount equal to the amount
     by which the market value of the Shares in respect of which the Option is
     exercised exceeds the Option Price payable in respect of those Shares, or
     Shares to the value of that cash amount, subject in both cases to rule
     10.8.

     If an Optionholder so requests, the Directors may determine to satisfy the
     exercise of any Option with the appropriate number of ADSs. Any payment of
     taxes in respect of satisfying an Option in this way will be met by the
     Optionholder.

9.5  Transfer:

     Subject to Rule 9.7 (consents), the Directors will procure the transfer of
     Shares following the exercise of an Option within 30 days of the Option
     Exercise Date.

9.6  Rights:

     Where Shares are to be transferred on the exercise of an Option,
     Optionholders will be entitled to all rights attaching to the Shares by
     reference to a record date on or after the transfer date. They will not be
     entitled to rights before that date.

9.7  Consents:

     All transfers of Shares will be subject to any necessary consents under any
     relevant enactments or regulations for the time being in force in the
     United Kingdom or elsewhere. The Optionholder will be responsible for
     complying with any requirements to be fulfilled in order to obtain or avoid
     the necessity for any such consent.

                                       7
<PAGE>

9.8  Articles of Association:

     Any Shares acquired on the exercise of Options will be subject to the
     Articles of Association of the Company from time to time in force. (Any
     ADSs acquired upon the exercise of any Option shall, in addition, be
     subject to the terms of the deposit agreement between the Company and the
     depository).

10   General

10.1 Notices:

     The provisions of the Company's Articles of Association for the time being
     on the service of notices on members will apply as far as possible (but
     altered if necessary) to any notice or other communications to be given
     under the Scheme to an Optionholder.

10.2 Documents sent to Shareholders:

     The Company may send to Optionholders copies of any documents or notices
     normally sent to the holders of its Shares (including such notices or
     documents required to be sent to Optionholders resident in the United
     States in accordance with the rules and regulations under the US Securities
     Exchange Act of 1934 as amended).

10.3 Availability of Shares:

     The Company will procure that sufficient Shares are available for transfer
     for all Options under which Shares may be acquired.

10.4 Directors' decisions final and binding:

     The decision of the Directors on the interpretation of the Rules or in any
     dispute relating to an Option or matter relating to the Scheme will be
     final and conclusive.

10.5 Regulations:

     The Directors have the power from time to time to make or vary regulations
     for the administration and operation of the Scheme but these must be
     consistent with the Rules.

10.6 Operation of the Scheme

     10.6.1 Whether or not the Scheme is operated is at the discretion of the
            Directors. Nothing in these Scheme rules or the operation of the
            Scheme will form part of the contract of employment or employment
            relationship of an Participant, employee or executive director or
            any other person (together, "Employees"). The rights and obligations
            of an Employee are separate from, and are not affected by, the
            Scheme.

     10.6.2 No Employee is entitled to participate in, or be considered for
            participation in, the Scheme at all or at a particular level and
            participation in one operation of the Scheme does not imply
            participation, or consideration for participation, in the next or
            any subsequent operation. Operation of the Scheme or participation
            in it shall not create any right to, or expectation of, continued
            employment.

                                       8
<PAGE>

     10.6.3 An Employee has no rights in respect of the operation of the Scheme
            or the exercise of any discretion or the taking of any decision
            which relates to, or affects, the Scheme. Any, and all, discretions
            and decisions whatsoever in respect of, or which affect, the Scheme
            may be exercised or taken in a manner which is detrimental to the
            Employee, even if such exercise or decision could be regarded as
            being capricious or unreasonable or in breach of any implied term
            between the Employee and his employer, including the implied duty of
            trust and confidence. Any such implied term is expressly excluded
            and overridden by this Rule 10.6.

     10.6.4 No Employee will have any right to compensation or damages or any
            other sum or benefit whatsoever in respect of the Scheme, including:

          (i)   in respect of eligibility to participate, or ceasing to be
                eligible to participate, or ceasing to participate in the
                Scheme;

          (ii)  any exercise of a discretion or decision taken in relation to
                the Scheme;

          (iii) any loss or reduction of any rights or expectation under the
                Scheme in any circumstances or for any reason (including lawful
                or unlawful termination of employment or the employment
                relationship);

          (iv)  the operation or amendment of the Scheme (whether to the
                detriment of the Employee or otherwise); and

          (v)   any other decision taken which affects the Scheme or its
                operation (whether to the detriment of the Employee or
                otherwise).

     10.6.5 Participation in the Scheme is permitted only on the basis that any
            rights as might otherwise arise are excluded and, in consideration
            for, and as a condition to, participating in the Scheme, the
            Employee waives all and any such rights.

     10.6.6 Nothing in this Scheme confers any benefit, right or expectation on
            a person who is not an Employee and no such third party will have
            any rights under the Contracts (Rights of Third Parties) Act 1999 to
            enforce any term of this Scheme, but this does not affect any right
            or remedy of a third party which exists or is available other than
            those available under that Act.

     10.6.7 For the avoidance of doubt, this rule will apply throughout any
            Employee's employment and will continue to apply even where an
            Employee has given or received notice to terminate his employment
            (whether such termination is lawful or unlawful) and following the
            termination of his employment (whether such termination is lawful or
            unlawful).

10.7 Employee Trust

     The Company and any Subsidiary may provide money to the trustee of any
     trust or any other person to enable them or him to acquire Shares to be
     held for the purposes of the Scheme, or enter into any guarantee or
     indemnity for those purposes, to the extent permitted by Section 153 of the
     Companies Act 1985.

                                       9
<PAGE>

10.8 Withholding

     The Company, any employing company or the trustees of any employee benefit
     trust may withhold any amount and make any such arrangements as it
     considers necessary to meet any liability to taxation or social security
     contributions in respect of Options granted to an Optionholder. These
     arrangements may include the sale of any Shares on behalf of the
     Optionholder, unless the Optionholder discharges the liability himself.

11   Changing the Scheme and Termination

11.1 Directors' powers

     Except as described in the rest of this Rule 11 the Directors may at any
     time change the Scheme in any way.

11.2 Shareholder approval

     11.2.1 Except as described in Rule 11.2.2, the Company in general meeting
            must approve in advance by ordinary resolution any proposed change
            to the advantage of present or future Optionholders, which relates
            to the following:

          (i)   the persons to or for whom Shares may be provided under the
                Scheme;

          (ii)  the individual limit for each Optionholder under the
                Scheme;

          (iii) the determination of the Option Price;

          (iv)  any rights attaching to the Options and the Shares;

          (v)   the rights of Optionholders in the event of a capitalisation
                issue, rights issue, sub-division or consolidation of shares or
                reduction or any other variation of capital of the Company;

          (vi)  the terms of this Rule 11.2.1.

     11.2.2 The Directors need not obtain the approval of the Company in general
            meeting for any minor changes:

          (i)   to benefit the administration of the Scheme;

          (ii)  to comply with or take account of the provisions of any proposed
                or existing legislation; or

          (iii) to obtain or maintain favourable tax, exchange control or
                regulatory treatment of the Company, any Subsidiary or any
                present or future Optionholder.

11.3 Overseas Employees

     Notwithstanding any other provision of the Scheme, the Directors may amend
     or add to the provisions of the Scheme and the terms of Options as they
     consider necessary or desirable to take account of, or to mitigate, or to
     comply with relevant overseas taxation, securities or exchange control
     laws, provided that the terms of Options granted to such Eligible Employees
     are not more favourable overall than the terms of Options granted to other
     Eligible Employees.

                                       10
<PAGE>

11.4 Data protection

     By participating in the Scheme the Optionholder consents to the holding and
     processing of personal data provided by the Optionholder to the Company for
     all purposes relating to the operation of the Scheme. These include, but
     are not limited to:

     11.4.1 administering and maintaining Optionholder records;

     11.4.2 providing information to trustees of any employee benefit trust,
            registrars, brokers or third party administrators of the Scheme;

     11.4.3 providing information to future purchasers of the Company or the
            business in which the Optionholder works;

     11.4.4 transferring information about the Optionholder to a country or
            territory outside the European Economic Area.

11.5 Termination of the Scheme The Scheme will terminate on the 10th anniversary
     of the adoption of the Scheme by the Company, but Options granted before
     such termination will continue to be valid and exercisable as described in
     these Rules.

12   Governing Law

     English law governs the Scheme and all Options and their construction.

                                       11Exhibit 10.30

                              ALFACELL CORPORATION
                             PURCHASE AGREEMENT FOR
                             COMMON STOCK & WARRANTS

Alfacell Corporation
225 Belleville Avenue
Bloomfield, New Jersey 07003

Attention: Kuslima Shogen, Chairman
           and Chief Executive Officer

Dear Ms. Shogen:

      The undersigned acknowledges that there is no minimum proceeds requirement
for the closing of this Offering, the Company may close only on the
undersigned's investment and such investment may be inadequate to meet the
Company's cash requirements. The Company intends to utilize the proceeds of this
Offering for research and development and general corporate purposes.

      The undersigned hereby subscribes to purchase _________ units at $_____
per unit (the "Unit"). Each Unit consists of one (1) share of Common Stock,
$.001 par value per share (the "Shares") of Alfacell Corporation, a Delaware
corporation (the "Company") and one (1) _______ year warrant (the "Warrants").
The Warrants are exercisable into one (1) Share (the "Warrant Shares"). The
Shares, the Warrants and the Warrant Shares are being sold in a transaction
exempt from registration under the Securities Act of 1933, as amended (the
"Act"). The Warrants will be issued pursuant to a Warrant Agreement in the form
attached hereto as Exhibit A executed by the Company for the benefit of the
undersigned. The Warrants will be exercisable at $_______ for a _______ year
period commencing three months after its issuance. The undersigned tenders
herewith $_____________ in full payment of the purchase price for the
___________ Units to which the undersigned subscribes (in the manner indicated
on the signature page hereof.)

      The undersigned understands that the right to transfer all or any part of
the Shares, the Warrants and the Warrant Shares (hereinafter sometimes
collectively referred to as the "Securities") will be restricted. The
undersigned may not transfer the Securities unless they are registered under the
Act and applicable state securities or "blue sky" laws, or an exemption from
such registration is available. The undersigned recognizes that the Company
shall have no obligation to register the Securities, except as set forth herein.

The undersigned hereby represents, warrants and covenant that:

      1. The undersigned is acquiring the Shares and the Warrants, and at such
time as the undersigned may exercise the Warrants, the Warrant Shares, for the
undersigned's own account for investment and not with a view towards
distribution. The undersigned will not sell, hypothecate, transfer or otherwise
dispose of the Securities unless such transaction has been registered under the
Act or, in the opinion of counsel for the Company, an exemption from
registration is available.

      2. (i) Please check here if the representation contained in this paragraph
2(i) is applicable to the undersigned _________. (A)If an individual, (a) the
undersigned's individual net worth or joint net worth

<PAGE>

with the undersigned's spouse exceeds $1,000,000 as of the date hereof, or (b)
the undersigned's individual income has been in excess of $200,000 in each of
2001 and 2000 and is expected to be in excess of $200,000 in 2002, or (c)the
undersigned's joint income with the undersigned's spouse has been in excess of
$300,000 in each of 2001 and 2000 and is expected to be in excess of $300,000 in
2002; or (B) if a corporation, partnership, or other entity, the foregoing
representation applies to all of the equity owners of the corporation,
partnership, or entity.

            (ii) If a corporation, partnership, or other entity, was such a
corporation, partnership, or other entity formed for the specific purpose of
acquiring the Shares? _____Yes _____ No

            (iii) If the answer to 2(ii) is yes, how many equity owners does the
corporation partnership or entity have? _____

      3. Whether or not the representation contained in paragraph 2(i)is
applicable to the undersigned, the undersigned has adequate means of providing
for the undersigned's current needs and possible contingencies and has no need
for liquidity of the Securities. The undersigned's overall commitment to
investments is not disproportionate to the undersigned's net worth, and
acquisition of the Securities will not cause such overall commitment to become
excessive. Prior to the execution hereof, the undersigned has received and had
the opportunity to review, examine and read all documents, records and books
pertaining to this investment, including the Company's Annual Report on Form
10-K for the fiscal year ended July 31, 2002, the Company's Quarterly Reports on
Form 10-Q for each of the three quarterly periods subsequent to the fiscal year
ended July 31, 2002 collectively, the "Disclosure Documents").

      4. The undersigned is knowledgeable and experienced in financial and
business matters. The undersigned recognizes and is fully cognizant of the fact
that the investment contemplated hereby involves a high degree of risk. The
undersigned is able to evaluate the merits and risks of an investment in the
Securities. The undersigned has been given an opportunity to ask questions of,
and receive answers and obtain information from, representatives of the Company
concerning the Company.

      5. The undersigned has been given no oral or written representations or
assurances by the Company or any other person acting or purporting to act on
behalf of the Company in connection with the acquisition of the Securities, in
each case except as provided herein or in the Disclosure Documents.

      6. The undersigned understands and specifically acknowledges and agrees
that since the Securities have not been registered under the Act, the
certificates representing the Securities will bear a legend to such effect and a
stop transfer order will be placed on the Securities in the Company's transfer
books.

      7. By its acceptance hereof, the Company hereby agrees that it shall use
its best efforts to file a registration statement (the "Registration Statement")
under the Act to register the resale of the Shares and the Warrant Shares. The
Company further agrees to use its best efforts to cause such Registration
Statement to become effective.

                                       2
<PAGE>

      In connection with the Registration Statement, the undersigned shall
provide the Company, from time to time, as reasonably requested by the Company,
written information concerning its ownership of the Company's Securities, their
intentions concerning the sale of its Shares and Warrant Shares and such other
matters as are required in order to enable the Company to prepare, file and
obtain the effectiveness of such Registration Statement. Notwithstanding any of
the foregoing, the Company shall not be required to maintain the effectiveness
of the Registration Statement for more than two (2) years after the initial
effective date thereof.

      In connection with any such registration of Shares and Warrant Shares, the
Company shall supply a reasonable number of prospectuses to the undersigned, use
its best efforts to qualify the Shares and Warrants for sale in the states of
New York and New Jersey and furnish indemnification in the manner set forth
below.

      The Company shall bear the entire cost and expense of any such
registration hereunder. Notwithstanding the foregoing, the undersigned shall
bear the fees of all persons retained by it, such as counsel and accountants,
and any transfer taxes or underwriting discounts or commissions applicable to
the Shares and Warrant Shares sold by it pursuant to the Registration Statement.

      The Company shall indemnify and hold harmless each holder of Shares and
Warrant Shares that are registered pursuant to the Registration Statement and
each underwriter, within the meaning of the Act, who may purchase from or sell
for any such holder any such Shares or Warrant Shares and each person, if any,
who controls any such holder or underwriter within the meaning of the Act, from
and against any and all losses, claims, damages and liabilities caused by any
untrue statement of a material fact contained in the Registration Statement or
any post-effective amendment thereto or any prospectus included therein required
to be filed or furnished in connection therewith or caused by any omission to
state therein a material fact required to be stated therein in order to make the
statements made therein, in light of the circumstances under which they were
made, not misleading, except insofar as such losses, claims, damages or
liabilities are caused by any such untrue statement or omission based upon
information furnished or required to be furnished in writing to the Company by
such holder or underwriter expressly for use therein; provided, however, that
such holder or underwriter shall indemnify the Company, its directors, each
officer signing the Registration Statement and each person, if any, who controls
the Company within the meaning of the Act, from and against any and all losses,
claims, damages and liabilities caused by any untrue statement of a material
fact contained in any Registration Statement or any post-effective amendment
thereto or any prospectus included therein required to be filed or furnished
pursuant thereto or caused by any omission to state therein a material fact
required to be stated therein in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading, insofar
as such losses, claims, damages or liabilities are caused by any untrue
statement or omission based upon information furnished in writing to the Company
by any such holder or underwriter expressly for use therein.

      If the indemnification provided for herein from either the holder of the
Shares and Warrant Shares or the Company is unavailable to an indemnified party
(the "Indemnitee") hereunder in respect of any losses, claims, damages

                                       3
<PAGE>

or liabilities (or actions in respect thereof) referred to herein, then the
party responsible for such indemnification (the "Indemnitor"), in lieu of
indemnifying the Indemnitee, shall contribute to the amount paid or payable by
the Indemnitee as a result of such losses, claims, damages or liabilities in
such proportion as is appropriate to reflect the relative fault of the
Indemnitor and Indemnitee in connection with the actions which resulted in such
losses, claims, damages or liabilities (including legal or other fees and
expenses reasonably incurred in connection with any investigation or proceeding)
as well as any other equitable considerations.

      If indemnification is available, the Indemnitor shall indemnify each
Indemnitee to the full extent provided for herein without regard to the relative
fault of the Indemnitor, the Indemnitee or any other equitable consideration
provided for hereunder.

      After the Registration Statement becomes effective and in connection with
the sale of the Shares and Warrant Shares under such Registration Statement, the
undersigned shall take such steps as may be necessary to ensure that the offer
and sale thereof are in compliance with the requirements of the federal
securities laws, including, but not limited to, compliance with the
anti-manipulation requirements of the Securities Exchange Act of 1934, as
amended.

                                       4
<PAGE>

      By its acceptance hereof, the Company hereby acknowledges that the
foregoing accurately reflects its understanding concerning the transaction
contemplated hereby.

                                         Very truly yours,

                                        ________________________________________
                                                    (Signature)

                                              Please type or print name
                                              (and title if applicable)

                                        Name & Address (as it should appear on
                                        certificates):

                                        ________________________________________

                                        ________________________________________

                                        ________________________________________

                                        Social Security Number or
                                        Taxpayer Identification Number

                                        (H) ________________ (W)____________
                                            Telephone Number

                                                    As of Date

                                                Number of Units

                                               Amount of Subscription
                                                  (U.S. Dollars)

ACCEPTED AND AGREED:                    Deliver to Address: (if
ALFACELL CORPORATION                    different from above)

                                        ________________________________________

___________________________________     ________________________________________
Name:

                    ________________________________________

                                       5
<PAGE>

                                    Exhibit A

      WARRANT TO PURCHASE ___________ SHARES OF COMMON STOCK VOID AFTER 5:00
p.m. NEW JERSEY TIME, ON ________________. THIS WARRANT AND THE SHARES OF COMMON
STOCK ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN AND WILL BE ISSUED IN
TRANSACTIONS WHICH HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "ACT"), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THIS
WARRANT AND SUCH SHARES MAY NOT BE SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR
OTHERWISE DISPOSED OF, IN WHOLE OR IN PART, IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE LAW, OR AN OPINION OF
COUNSEL ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

NO. ______                                                         ______ SHARES

                              ALFACELL CORPORATION

      This certifies that, for value received, ___________________________, the
registered holder hereof or assigns (the "Warrantholder") is entitled to
purchase from Alfacell Corporation, a Delaware corporation (the "Company"), at
any time on and after ___________________, and before 5:00 p.m., New Jersey
time, on _______________ (the "Termination Date"), at the purchase price of
$_______ per share (the "Exercise Price"), the number of shares of Common Stock,
par value $.001 per share, of the Company set forth above (the "Warrant Stock").
The number of shares of Warrant Stock, the Termination Date and the Exercise
Price per share of this Warrant shall be subject to adjustment from time to time
as set forth below.

SECTION I. TRANSFER OR EXCHANGE OF WARRANT.

      The Company shall be entitled to treat the Warrantholder as the owner in
fact hereof for all purposes and shall not be bound to recognize any equitable
or other claim to or interest in this Warrant on the part of any other person.
This Warrant shall be transferable only on the books of the Company, maintained
at its principal office upon delivery of this Warrant Certificate duly endorsed
by the Warrantholder or by his duly authorized attorney or representative, or
accompanied by proper evidence of succession, assignment or authority to
transfer. Upon any registration of transfer, the Company shall deliver a new
Warrant Certificate or Certificates to the persons entitled thereto.

SECTION II. TERM OF WARRANT; EXERCISE OF WARRANTS.

      A. Termination. The Company may, in its sole discretion, extend the
Termination Date with respect to the exercise of this Warrant upon notice to the
Warrantholder. As used herein, "Termination Date" shall be deemed to include any
such extensions.

      B. Exercise. This Warrant shall be exercised by surrender to the Company,
at its principal office, of this Warrant Certificate, together with the Purchase
Form attached hereto duly completed and signed, and upon payment to the Company
of the Exercise Price for the number of shares of Warrant Stock in respect of
which this Warrant is then exercised. Payment of the aggregate Exercise Price
shall be made in cash or by certified or official bank check.

      C. Warrant Certificate. Subject to Section III hereof, upon such surrender
of this Warrant Certificate and payment of the Exercise Price as aforesaid, the
Company shall issue and cause to be delivered to or upon the written order of
the Warrantholder a certificate or certificates for the number of full shares of
Warrant Stock so purchased upon the exercise of such Warrant, together with
cash, as provided in Section VI hereof, in respect of any fractional shares of
Warrant Stock otherwise issuable upon such surrender. Such certificate or
certificates representing the Warrant Stock shall be deemed to have been issued
and any person so designated to be named therein shall be deemed to have become
a holder of record of such shares of Warrant Stock as of the date of receipt by
the Company of this Warrant

                                       6
<PAGE>

Certificate and payment of the Exercise Price as aforesaid; provided, however,
that if, at the date of surrender of this Warrant Certificate and payment of the
Exercise Price, the transfer books for the Warrant Stock or other class of stock
purchasable upon the exercise of this Warrant shall be closed, the certificate
or certificates for the shares of Warrant Stock in respect of which this Warrant
is then exercised shall be deemed issuable as of the date on which such books
shall next be opened (whether before or after the Termination Date) and until
such date the Company shall be under no duty to deliver any certificate for such
shares of Warrant Stock; provided further, however, that the transfer books of
record, unless otherwise required by law, shall not be closed at any one time
for a period longer than twenty (20) days. The rights of purchase represented by
this Warrant shall be exercisable, at the election of the Warrantholder, either
in full or from time to time in part, and, in the event that this Warrant is
exercised in respect of fewer than all of the shares of Warrant Stock
purchasable on such exercise at any time prior to the Termination Date, a new
Warrant Certificate evidencing the remaining Warrant or Warrants will be issued,
and the Company shall deliver the new Warrant Certificate or Certificates
pursuant to the provisions of this Section.

SECTION III. PAYMENT OF TAXES.

      The Company will pay all documentary stamp taxes, if any, attributable to
the initial issuance of the shares of Warrant Stock upon the exercise of this
Warrant; provided, however, that the Warrantholder shall pay any tax or taxes
which may be payable in respect of any transfer involved in the issue or
delivery of Warrant Certificates or the certificates for the shares of Warrant
Stock in a name other than that of the Warrantholder in respect of which this
Warrant or shares of Warrant Stock are issued.

SECTION IV. MUTILATED OR MISSING WARRANT CERTIFICATES.

      In case this Warrant Certificate shall be mutilated, lost, stolen or
destroyed, the Company shall, at the request of the Warrantholder, issue and
deliver, in exchange and substitution for and upon cancellation of this
certificate if mutilated, or in lieu of and in substitution for this certificate
if lost, stolen or destroyed, a new Warrant Certificate of like tenor and
representing an equivalent right or interest, but only upon receipt of evidence
satisfactory to the Company of such loss, theft or destruction of this Warrant
Certificate and indemnity, if requested, also satisfactory to the Company.

SECTION V. RESERVATION OF SHARES OF WARRANT STOCK.

      There has been reserved, and the Company shall at all times keep reserved
so long as this Warrant remains outstanding, out of its authorized Common Stock
a number of shares of Common Stock sufficient to provide for the exercise of the
rights of purchase represented by this Warrant. The transfer agent for the
Common Stock and every subsequent transfer agent for any shares of the Company's
capital stock issuable upon the exercise of this Warrant will be irrevocably
authorized and directed at all times to reserve such number of authorized shares
as shall be requisite for such purpose.

SECTION VI. FRACTIONAL SHARES.

      No fractional shares or scrip representing fractional shares shall be
issued upon the exercise of this Warrant. With respect to any fraction of a
share called for upon the exercise of this Warrant, the Company shall pay to the
Warrantholder an amount in cash equal to such fraction multiplied by the current
market price of such fractional share. "Market Price", as of any date means, (i)
the last reported sale price for the shares of Common Stock as reported by the
National Association of Securities Dealers Automated Quotation National Market
System, ("NASDAQ-NMS"), (ii) the closing bid price for the shares of Common
Stock as reported by the National Association of Securities Dealers Automated
Quotation System ("NASDAQ") if the shares are not traded on NASDAQ-NMS, (iii)
the average of the closing bid and closing asked prices of the Common Stock as
reported by the National Quotations Bureau if the shares are not traded on
NASDAQ; (iv) the last reported sale price, if the shares of Common Stock are
listed on a national securities exchange or (v) if market value cannot be
calculated as of such date on any of the foregoing basis, the fair market price
determined by the Board of Directors of the Company, acting with reasonable
business judgment.

                                       7
<PAGE>

SECTION VII. EXERCISE PRICE; ANTI-DILUTION PROVISIONS.

      A. Exercise Price. The shares of Warrant Stock shall be purchasable upon
the exercise of this Warrant, at a price of $____ per share. The Company may, in
its sole discretion, reduce the Exercise Price applicable to the exercise of
this Warrant upon notice to the Warrantholder. As used herein, "Exercise Price"
shall be deemed to include any such reduction.

      If the Company shall at any time issue Common Stock by way of dividend or
other distribution on any stock of the Company or effect a stock split or
reverse stock split of the outstanding shares of Common Stock, the Exercise
Price shall be proportionately decreased in the case of such issuance (on the
day following the date fixed for determining stockholders entitled to receive
such dividend or other distribution or such stock split) or increased in the
case of such reverse stock split (on the date that such reverse stock split
shall become effective), by multiplying the Exercise Price in effect immediately
prior to the stock dividend or other distribution, stock split or reverse stock
split by a fraction, the numerator of which is the number of shares of Common
Stock outstanding immediately prior to such stock dividend or other
distribution, stock split or reverse stock split, and the denominator of which
is the number of shares of Common Stock outstanding immediately after such stock
dividend or other distribution, stock split or reverse stock split.

      B. No Impairment. The Company (a) will not increase the par value of any
shares of stock receivable upon the exercise of this Warrant above the amount
payable therefor upon such exercise, and (b) will take all such action as may be
necessary or appropriate in order that the Company may validly and legally issue
fully paid and nonassessable shares of Common Stock upon the exercise of this
Warrant.

      C. Number of Shares Adjusted. Upon any adjustment of the Exercise Price
pursuant to this Warrant, the Warrantholder shall thereafter (until another such
adjustment) be entitled to purchase upon the exercise of this Warrant, at the
new Exercise Price, the number of shares, calculated to the nearest full share,
obtained by multiplying the number of shares of Warrant Stock initially issuable
upon exercise of this Warrant by the Exercise Price in effect on the date hereof
and dividing the product so obtained by the new Exercise Price.

SECTION VIII. RECLASSIFICATION, REORGANIZATION OR MERGER.

      In case of any reclassification, capital reorganization or other change of
outstanding shares of Common Stock of the Company (other than a change in par
value or as a result of an issuance of Common Stock by way of dividend or other
distribution or of a stock split or reverse stock split) or in case of any
consolidation or merger of the Company with or into another corporation (other
than a merger with a subsidiary in which merger the Company is the continuing
corporation and which does not result in any reclassification, capital
reorganization or other change of outstanding shares of Common Stock of the
Company issuable upon exercise of this Warrant) or in case of any sale or
conveyance to another corporation of the property of the Company as an entirety
or substantially as an entirety, the Company shall cause effective provision to
be made so that the Warrantholder shall have the right thereafter, by exercising
this Warrant, to purchase the kind and amount of shares of stock and other
securities and property the Warrantholder would have been entitled to receive if
the Warrantholder had exercised this Warrant immediately prior to such
reclassification, capital reorganization or other change, consolidation, merger,
sale or conveyance. Any such provision shall include provision for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Warrant. The foregoing provisions of this Section shall
similarly apply to successive reclassifications, capital reorganizations and
changes of shares of Common Stock and to successive consolidations, mergers,
sales and conveyances.

SECTION IX. REGISTRATION RIGHTS.

      A. The Warrantholder shall have the registration rights with respect to
the resale of the Warrant Stock as set forth in Section 7 of the Purchase
Agreement by and between the Company and the Warrantholder of even date
herewith.

                                       8
<PAGE>

SECTION X. NOTICES TO WARRANTHOLDERS.

      So long as this Warrant shall be outstanding and unexercised (a) if the
Company shall pay any dividend or make any distribution upon the Common Stock or
(b) if the Company shall offer to the holders of Common Stock for subscription
or purchase by them any shares of stock of any class or any other rights or (c)
if any capital reorganization of the Company, reclassification of the capital
stock of the Company, consolidation or merger of the Company with or into
another corporation, sale, lease or transfer of all or substantially all of the
assets of the Company to another corporation, or the voluntary or involuntary
dissolution, liquidation or winding up of the Company shall be effected, then,
in any such case, the Company shall cause to be delivered to the Warrantholder,
at least ten days prior to the date specified in (i) or (ii) below, as the case
may be, a notice containing a brief description of the proposed action and
stating the date on which (i) a record is to be taken for the purpose of such
dividend or distribution, or (ii) such reclassification, reorganization,
consolidation, merger, conveyance, lease, dissolution, liquidation or winding up
is to take place and the date, if any, as of which the holders of Common Stock
of record shall be entitled to exchange their shares of Common Stock for
securities or other property deliverable upon such reclassification,
reorganization, consolidation, merger, conveyance, dissolution, liquidation or
winding up.

SECTION XI. NOTICES.

      Any notice pursuant to this Warrant by the Company or by the Warrantholder
shall be in writing and shall be deemed to have been duly given if delivered or
mailed certified mail, return receipt requested, (a) if to the Company, to it at
225 Belleville Avenue, Bloomfield, New Jersey 07003, Attention: Chief Executive
Officer and (b) if to the Warrantholder to the Warrantholder at the address set
forth on the signature page hereto. Each party hereto may from time to time
change the address to which such party's notices are to be delivered or mailed
hereunder by notice in accordance herewith to the other party.

SECTION XII. SUCCESSORS.

      All the covenants and provisions of this Warrant by or for the benefit of
the Company or the Warrantholder shall bind and inure to the benefit of their
respective successors and assigns hereunder.

SECTION XIII. APPLICABLE LAW.

      This Warrant shall be deemed to be a contract made under the laws of the
State of Delaware applicable to agreements made and to be performed entirely in
Delaware and for all purposes shall be construed in accordance with the internal
laws of Delaware without giving effect to the conflicts of laws principles
thereof.

SECTION XIV. BENEFITS OF THIS WARRANT.

      Nothing in this Warrant shall be construed to give to any person or
corporation other than the Company and the Warrantholder any legal or equitable
right, remedy or claim under this Warrant and this Warrant shall be for the sole
and exclusive benefit of the Company and the Warrantholder.

                                       9
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this Warrant
Certificate or caused this Warrant Certificate to be duly executed as of the day
and year first above written.

ALFACELL CORPORATION

By: _______________________________
Name: Kuslima Shogen
Title: Chairman and Chief
       Executive Officer

WARRANTHOLDER

___________________________________
Name:

Address:

Social Security or
Taxpayer Identification Number

                                       10
<PAGE>

                                  PURCHASE FORM

      The undersigned hereby irrevocably elects to exercise the Warrant
represented by this Warrant Certificate to the extent of _____ shares of Common
Stock, par value $.001 per share, of Alfacell Corporation, and hereby makes
payment of $_______ in payment of the actual exercise price thereof.

Name: _____________________________________________________________
                     (Please type or print in block letters)

Address: __________________________________________________________
                   (Address for delivery of Stock Certificate)

Social Security or
Taxpayer Identification Number: ___________________________________

Signature:_________________________________________________________

                                       11
<PAGE>

                                 ASSIGNMENT FORM

FOR VALUED RECEIVED, _____________________________ hereby sells, assigns and
transfers unto ______________________________________
                    (Please type or print in block letters)

Address__________________________________________________________
the right to purchase Common Stock, par value $.001 per share, of Alfacell
Corporation, represented by this Warrant Certificate to the extent of __________
shares as to which such right is exercisable and does hereby irrevocably
constitute and appoint ______________________, to transfer the same on the books
of the Company with full power of substitution in the premises.

___________________________________
            Signature

Dated:

                                        Notice: The signature of this assignment
                                        must correspond with the name as it
                                        appears upon the face of this Warrant
                                        Certificate in every particular, without
                                        alteration or enlargement or any change
                                        whatever.

SIGNATURE GUARANTEED:

___________________________________

                                       12
<PAGE>

                                    SCHEDULE

The following Purchase Agreement was issued to the following individuals, upon
the following terms:

                                                          Warrants Issued
                                                  ------------------------------
Date           Investor        # of Units  Price  Term   Exercise Price  Number
----           --------        ----------  -----  -----  --------------  -------

June 2002      Charles Muniz   142,857     $0.35  5 yrs      $1.00       142,857
June 2002      Melba Muniz     142,857     $0.35  5 yrs      $1.00       142,857
October 2002   Karen Anthony    35,000     $0.20  5 yrs      $1.00        35,000

                                       13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}]]